<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04196738</url>
  </required_header>
  <id_info>
    <org_study_id>49RC19_0195</org_study_id>
    <nct_id>NCT04196738</nct_id>
  </id_info>
  <brief_title>Comparison of Volume Assist Control, Dual Mode and Airway Pressure Release Ventilation.</brief_title>
  <acronym>COMIX-R</acronym>
  <official_title>Comparison of Volume Assist Control, Dual Mode and Airway Pressure Release Ventilation: A Physiological Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the COMIX-R study is to assess the short term physiological effects of 3
      ventilation strategies for adult patients with ARDS admitted to intensive care unit
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2, 2019</start_date>
  <completion_date type="Anticipated">November 18, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 18, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>patients exposed to 3 ventilatory mode in 2 different possible orders</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change of PaO2 (mmHg)</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>Arterial partial pressure of dioxygen Of note: As it is a physiological study, all the primary and secondary outcomes will be analyzed with the same importance.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>-Respiratory rate variability</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>variability of rate (per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-expiratory and inspiratory transpulmonary pressure</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>calculated with the esophageal pressure (cm H20)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-ventilation distribution in the lungs</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>Electrical impedance tomography (EIT) assess distribution of tidal volume and of end-expiratory lung volume (EELV) (delta Z, IU)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-other arterial parameters of hematosis</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>pH, PaO2, PaCo2 (mmHg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-Work of breathing (WOB)</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>calculated with esophageal pressure (Kg/m)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-Pressure time product (PTP)</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>-Pressure time product (PTP) calculated with esophageal pressure (cmH2O.s.min-1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-P0.1</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>pressure measured during the first 100 ms after an occlusion (cm H20)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-PEEPi</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>intrinsic positive end-expiratory pressure (cm H20)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MAP</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>mean arterial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HR</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>heart rate (beats per minute)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-Respiratory comfort</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>visual analogic scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-Patient-ventilator asynchronies</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>numbers of asynchronies analyzed on screen</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>-Tidal volume variability</measure>
    <time_frame>15 minutes, 1 hour, 1hour and 45 minutes, 2 hour and 30 minutes</time_frame>
    <description>variability of Tidal volume (mL)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>ARDS</condition>
  <arm_group>
    <arm_group_label>Dual Mode first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four consecutive steps (45 min per step) in the following order: APRV (A), Dual Mode (B) , APRV (A) and VAC (C). (ABAC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VAC fist</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Four consecutive steps (45 min per step) in the following order: APRV (A), VAC (C) , APRV (A) and Dual Mode (B). (ACAB)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ventilation strategy</intervention_name>
    <description>Patients are ventilated in randomised order with three different ventilation strategies: volume assist control (constant flow), Dual Mode or Airway Pressure Released Ventilation</description>
    <arm_group_label>Dual Mode first</arm_group_label>
    <arm_group_label>VAC fist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or older

          -  Invasive mechanical ventilation on tracheal probe

          -  Acute respiratory distress syndrome, as defined by Berlin conference consensus, during
             hospitalization in intensive care,

          -  Recovery phase of acute respiratory distress syndrome: spontaneous ventilation
             representing from 20 to 30% of ventilation in APRV mode.

          -  No severe acidosis (pH&gt; 7.30)

          -  Patient affiliated to or beneficiary of a health care plan

          -  Express consent of the patient or his/her SDM

        Exclusion Criteria:

          -  Pneumothorax

          -  Contraindication to the insertion of a nasogastric tube with an esophageal balloon

          -  Contraindication to the use of Electrical impedance tomography (pacemaker)

          -  Pregnancy, lactating or parturient woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francois BELONCLE, CCU-AH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Angers teatching hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fran√ßois BELONCLE, CCU-AH</last_name>
    <phone>+33 2 41 35 38 45</phone>
    <email>Francois.Beloncle@chu-angers.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Francois BELONCLE, CCU-AH</last_name>
      <phone>+33 2 4135 38 45</phone>
      <email>Francois.Beloncle@chu-angers.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 12, 2019</study_first_submitted>
  <study_first_submitted_qc>December 11, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 12, 2019</study_first_posted>
  <last_update_submitted>December 11, 2019</last_update_submitted>
  <last_update_submitted_qc>December 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

